26 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from SAI-Med Partners LLC's own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Next end date: 2027-03-31. Employing an H-1B worker past the LCA end date without a new certified LCA is a strict-liability violation — the replacement LCA must be certified before the I-129 extension is filed.
Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.
Multi-position LCAs are efficient, but every unused position must be withdrawn and every filled position needs its own PAF entry.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 55% above the DOL prevailing wage across 10 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — SAI-Med Partners LLC sponsors H-1B workers, with 26 certified LCAs on file (FY2021–FY2026), including 4 in FY2026. The median certified salary is $100,000 (P25 $81,250, P75 $130,000). 100% of its certified filings meet or exceed the prevailing wage.
SAI-Med Partners LLC H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 68% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 6 | 0 | 0 | 6 |
| FY2022 | 4 | 0 | 0 | 4 |
| FY2023 | 6 | 0 | 0 | 6 |
| FY2024 | 3 | 0 | 0 | 3 |
| FY2025 | 3 | 0 | 0 | 3 |
| FY2026 | 4 | 0 | 0 | 4 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Associate Director - Generics, Biosimilars and Mature Brands I-200-26162-006216 | $120,000/yr | IV | Reading, PA | Jun 11, 2026 | Certified |
Life Sciences Markets Consultant I-200-26152-967879 | $85,000/yr | II | Reading, PA | Jun 01, 2026 | Certified |
Exec Director - Specialty Therapeutics and Related (STAR) I-200-26099-776536 | $145,000/yr | II | Reading, PA | Apr 09, 2026 | Certified |
Vice President, Oncology Practice I-200-26097-765523 | $185,000/yr | III | Reading, PA | Apr 07, 2026 | Certified |
Life Sciences Markets Consultant/Project Manager I-200-25168-102610 | $88,000/yr | III | Reading, PA | Jun 17, 2025 | Certified |
Life Sciences Markets Consultant/Project Manager I-200-25084-801920 | $115,000/yr | III | Reading, PA | Mar 25, 2025 | Certified |
Life Sciences Markets Consultant/Project Manager I-200-24354-557557 | $100,000/yr | III | Reading, PA | Dec 19, 2024 | Certified |
Associate Director, Immunology Practice I-200-24170-124575 | $135,200/yr$65/hr as filed | II | Reading, PA | Jun 18, 2024 | Certified |
Life Sciences Markets Consultant/Project Manager I-200-24072-793272 | $100,000/yr | III | Reading, PA | Mar 12, 2024 | Certified |
TheraTraQ Pharma/Healthcare Services Division Head I-200-24064-768831 | $200,000/yr | IV | Reading, PA | Mar 04, 2024 | Certified |
Life Sciences Markets Consultant/Project Manager I-200-23256-344742 | $80,000/yr | III | Reading, PA | Sep 13, 2023 | Certified |
Senior Director, Oncology Practice I-200-23220-247983 | $145,000/yr | III | Reading, PA | Aug 08, 2023 | Certified |
Director - Specialty Therapeutics and Related (STAR) I-200-23198-193274 | $130,000/yr | I | Reading, PA | Jul 17, 2023 | Certified |
Life Sciences Markets Consultant I-200-23163-100588 | $85,000/yr | II | Los Angeles, CA | Jun 12, 2023 | Certified |
Assoc Director - Specialty Therapeutics and Related (STAR) I-200-23163-100786 | $110,000/yr | IV | Reading, PA | Jun 12, 2023 | Certified |
Life Sciences Markets Consultant I-200-23101-923652 | $85,000/yr | II | Reading, PA | Apr 11, 2023 | Certified |
Life Sciences Markets Consultant I-200-22159-257843 | $72,000/yr | III | Reading, PA | Jun 08, 2022 | Certified |
Associate Director, Immunology Practice I-200-22088-019156 | $120,000/yr | II | Reading, PA | Mar 29, 2022 | Certified |
Director, Oncology Practice I-200-22038-884034 | $130,000/yr | II | Reading, PA | Feb 07, 2022 | Certified |
Life Sciences Markets Consultant I-200-22025-853398 | $60,000/yr | III | Reading, PA | Jan 25, 2022 | Certified |
Life Sciences Markets Consultant I-200-21253-577495 | $72,500/yr | — | Reading, PA | Sep 10, 2021 | Certified |
Life Sciences Markets Consultant I-200-21218-507544 | $79,000/yr | III | Reading, PA | Aug 06, 2021 | Certified |
Life Sciences Markets Consultant/Project Manager I-200-21181-438452 | $90,000/yr | IV | Reading, PA | Jun 30, 2021 | Certified |
TheraTraQ Pharma/Healthcare Services Division Head I-200-21176-427241 | $175,000/yr | III | Reading, PA | Jun 25, 2021 | Certified |
Life Sciences Markets Consultant I-200-21172-414414 | $72,500/yr | III | Reading, PA | Jun 21, 2021 | Certified |
Life Sciences Markets Consultant I-200-21169-410653 | $72,500/yr | III | Reading, PA | Jun 18, 2021 | Certified |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Jun and Mar — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
2 states · 2 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →